Sequel Pharmaceuticals, Inc.

12750 High Bluff Drive,
San Diego, California 92130
United States,
++1 858-509-0455
www.sequelpharma.com

Sequel Pharmaceuticals (San Diego, CA) is a pharmaceutical company focused on the treatment of cardiovascular disease.

Sequel Pharmaceuticals was acquired by Montreux Equity Partners on September 27, 2007.

Join Mergr to view all 156 acquisitions of medical products companies in 2007, including 33 acquisitions by private equity firms, and 123 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 9 in number of deals in 2007. The largest medical products acquisition in 2007 was MedImmune - which was acquired by AstraZeneca for $15.6B.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Sequel Pharmaceuticals.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.